View More Recent Stories

Aug 31, 2023 08:00AM Rallybio to Present at Upcoming Investor Conferences in September
Aug 8, 2023 08:00AM Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
Aug 2, 2023 08:00AM Rallybio to Present at the 2023 Wedbush PacGrow Healthcare Conference
Jul 11, 2023 08:00AM Rallybio Announces Acceptance of Abstract for RLYB116 at the 29th International Complement Workshop (ICW)
Jun 29, 2023 07:03AM Rallybio Corporation (RLYB) Appoints Stephen Uden as Next CEO
Jun 29, 2023 07:00AM Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Jun 24, 2023 03:30PM  Rallybio Announces Proof-of-Concept Results and Development Updates for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
View More Recent Stories